AAO Decisions Explorer · Free
Published AAO appeal decisions
Search the decisions the Administrative Appeals Office has published, narrow them by visa, criterion, field and year, and read our summary of each one with a link to the official PDF.

Decisions in the library
6,586
6,586 classified
Visa types
3
Years covered
2005-2026
Latest decision
Aug 31, 2026
Filters
51 decisions
Outcomes in these results
- Dismissed
- Remanded
- Sustained
- EB-2 NIWBiotech and pharmaMar 2025Dismissed
Biomedical systems technician seeks NIW to establish business providing clinical engineering services, equipment maintenance, and training. AAO dismissed appeal, finding the petitioner failed to demonstrate national importance of the proposed endeavor, lacking evidence of substantial economic impact, job creation, or industry-wide implications beyond prospective clients.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaFeb 2025Dismissed
A biomedical scientist and clinical pathology technician sought EB-2 with national interest waiver. The AAO dismissed the appeal, holding that the proposed biomedical company's services and training would not extend beyond individual clients to have national importance or broader field impact.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaFeb 2025Dismissed
Pharmaceutical sales representative with advanced degree seeks EB-2 national interest waiver for health-related project. Petitioner claimed national importance through health and economic benefits. AAO held substantial merit shown but national importance unmet; endeavor lacks evidence of broader field or regional impact exceeding specific occupational role.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaDec 2024Sustained
A physician-researcher pursuing a Ph.D. in biomedical sciences seeks NIW for research on breast cancer biomarkers and early detection. The petitioner claimed three Dhanasar prongs. The AAO sustained the appeal, finding the proposed research has substantial merit and national importance, the petitioner is well-positioned to advance it given his medical degree and publication record, and waiving job offer requirements would benefit the United States.
3 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaNov 2024Dismissed
Biomedical engineer researcher proposed postdoctoral research on brain cognitive processes using machine learning. AAO withdrew denial of prong one, finding national importance, but affirmed denial under prong two because petitioner lacked demonstrated influence or record of success advancing the field.
1 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaAug 2024Dismissed
A bioengineer and prosthetics researcher sought EB-2 classification with a national interest waiver. The AAO dismissed the appeal, finding she failed to establish a U.S. bachelor's or advanced degree equivalent and, even under exceptional ability, did not meet three evidentiary criteria. The proposed endeavor lacked specific evidence of national importance.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaAug 2024Dismissed
Bioanalyst and high school teacher seeking NIW for consulting business in bioanalysis and STEM education. Claimed endeavor would advance science education and economic growth. AAO dismissed appeal, finding proposed endeavor lacked national importance and petitioner not well-positioned to advance it.
0 of 3 criteria metRead → - EB-1ABiotech and pharmaJul 2024Dismissed
A biomedical engineer researcher sought EB-1A classification. The AAO affirmed that he met three initial criteria but dismissed his appeal, finding he failed to demonstrate sustained national or international acclaim or that he ranks among the very top of his field despite accomplishments.
3 of 4 criteria metRead → - EB-2 NIWBiotech and pharmaApr 2024Dismissed
Pharmacist and entrepreneur sought NIW to operate business providing parenteral nutrition products. AAO affirmed denial, finding petitioner failed to describe proposed endeavor with sufficient specificity and provide corroborating evidence that business activities would achieve substantial national economic impact.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaMar 2024Dismissed
Bioengineering technology researcher seeking NIW for EB-2. AAO agreed endeavor has national importance but held she is not well-positioned to advance it because her research lacks substantial citations, field impact, and evidence of obtaining funding, failing the second Dhanasar prong.
1 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaFeb 2024Dismissed
Pharmaceutical professional seeking EB-2 exceptional ability classification and national interest waiver. AAO dismissed appeal because petitioner failed to meet three initial evidentiary criteria for exceptional ability and did not establish specific endeavor or its prospective national importance under Dhanasar framework.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaJan 2024Dismissed
An entrepreneur with pharmacy and diagnostic laboratory expertise seeks EB-2 NIW to open a low-cost diagnostic lab in an economically depressed region. AAO dismissed because the proposed endeavor lacks national importance; a small business serving local patients and employing 22 workers does not meet Dhanasar's requirement for broader field impact or substantial national economic benefit.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaNov 2023Sustained
Biomedical engineer seeks NIW for EB-2 advanced degree classification to conduct cell and gene therapy research. Meets all three Dhanasar prongs: proposed endeavor has national importance, petitioner is well-positioned through credentials and research record, and waiving job offer benefits the United States.
3 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaMar 2022Sustained
A cancer biology researcher with a Ph.D. sought a national interest waiver for EB-2 classification to conduct research on targeted cancer therapies. The AAO sustained the appeal, finding all three Dhanasar prongs satisfied: the research has substantial merit and national importance, she is well positioned to advance it, and the waiver benefits the United States.
3 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaMar 2022Dismissed
A medical scientist in dentistry sought EB-2 advanced degree classification with a national interest waiver for proposed oral health research. The AAO found the research had substantial merit and national importance but the petitioner was not well positioned to advance it, as education alone was insufficient and she lacked a documented record of research success or implementation.
1 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaAug 2021Dismissed
A pharmaceutical chemist and assistant professor sought NIW classification. The AAO dismissed the appeal, finding the petitioner failed to establish substantial merit and national importance of the proposed endeavor under Dhanasar's first prong because the endeavor remained vague and lacked evidence of broader field impact.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaJul 2021Dismissed
Chemist self-petitioner sought national interest waiver for EB-2 exceptional ability in drug development. AAO dismissed appeal because petitioner failed to sufficiently describe her specific proposed future work, preventing analysis of substantial merit, national importance, or positioning.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaJun 2021Dismissed
A chemist with Ph.D. in organic chemistry sought national interest waiver. AAO found she met the first two Dhanasar prongs but failed the third, concluding waiver was not warranted because her fellowship was time-limited, her citation metrics were deficient, and publication benefits were contingent on academic versus commercial employment.
2 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaJun 2021Dismissed
Pharmaceutical scientist seeks national interest waiver of job offer requirement under EB-2. Met first prong showing substantial merit and national importance of proposed drug formulation research, but failed second prong lacking sufficient evidence of positioning to advance the work.
1 of 3 criteria metRead → - EB-1ABiotech and pharma2021Dismissed
Quality assurance associate in pharmaceutical industry sought EB-1A extraordinary ability classification. Claimed four criteria; director found two met. AAO dismissed, holding petitioner failed to meet three of ten required criteria and lacks the sustained acclaim and top-tier recognition required.
2 of 6 criteria metRead → - EB-1ABiotech and pharmaMay 2020Dismissed
A biomolecular researcher claimed extraordinary ability and met three initial criteria: judging, original contributions, and scholarly articles. AAO proceeded to final merits analysis and found record did not establish sustained national or international acclaim or top-tier achievement.
3 of 11 criteria metRead → - EB-1ABiotech and pharmaFeb 2020Dismissed
Biotechnologist in immunology sought EB-1A extraordinary ability classification. AAO confirmed petitioner met three evidentiary criteria (judging, scholarly articles, leading role) but dismissed appeal because totality of evidence failed to establish sustained national or international acclaim or placement among the very top of the field.
3 of 4 criteria metRead → - EB-1ABiotech and pharmaDec 2019Dismissed
A postdoctoral researcher in biomedical engineering working on gene therapy sought EB-1A extraordinary ability. The AAO confirmed two criteria met: judging and scholarly articles. The petitioner's claimed original contributions in gene therapy delivery were rejected as lacking evidence of major significance or field impact, failing the threshold of three criteria.
2 of 4 criteria metRead → - EB-2 NIWBiotech and pharma2018Sustained
A biostatistics researcher with a Ph.D. sought an EB-2 national interest waiver. He proposed research improving clinical trial design and quality-of-life studies. The AAO sustained his appeal, finding all three Dhanasar prongs satisfied: substantial merit and national importance, well-positioned qualifications, and net benefit to the nation.
3 of 3 criteria metRead → - EB-1ABiotech and pharma2013Dismissed
A biological engineer sought EB-1A classification asserting three or more criteria. The AAO dismissed, finding insufficient qualifying evidence under at least three criteria. Evidence offered on appeal for criteria not previously claimed was properly rejected.
0 of 6 criteria metRead →
